Advancements in pancreatic cancer screening have led to research-based guidelines for screening high-risk individuals, including those with a family history or genetic mutations. Screening involves MRI and endoscopic ultrasound tests conducted annually to detect the disease at an early stage. Genetic testing and AI are being used to improve risk assessment and screening accuracy. Collaborative research is ongoing to identify additional indicators for pancreatic cancer risk, with the goal of implementing innovative technologies to enhance early detection and overall survival rates. There is hope for improved outcomes with early detection and monitoring.
Source link
What you should know about pancreatic cancer screening
